Nathaniel Lipkus

Nathaniel Lipkus has distinguished himself as a leading authority in the intersection of intellectual property and technology, particularly within the domains of artificial intelligence and biotech. His adept handling of patent disputes and his strategic guidance on IP litigation underscore his expertise. Notably, Nathaniel's role in groundbreaking patent eligibility cases for software and life sciences has set legal precedents, underscoring his influence in the field.

Beyond litigation, Nathaniel is a trusted advisor on regulatory matters affecting life sciences entities, adeptly navigating the complexities of health product approvals and IP issues. His work with emerging companies, especially in managing IP during significant transactions, showcases his ability to tailor strategies that protect and leverage intellectual assets effectively.

His contributions to the legal community extend to education, where he imparts knowledge on international trade-related IP matters, demonstrating his commitment to nurturing the next generation of legal professionals. Nathaniel's work with the Canadian Alternative Reference Rate work group illustrates his forward-thinking approach, particularly in adapting financial markets to new benchmark rates.

Nathaniel's recognition by Chambers Canada, The Canadian Legal Lexpert Directory, and Best Lawyers in Canada, among others, is a testament to his professional excellence and impact on the legal landscape. His involvement in significant IP cases, including representing the Children’s Hospital of Eastern Ontario in gene patent litigation, highlights his commitment to meaningful legal work.

Nathaniel's bilingual proficiency enables him to serve a broad client base, further amplifying his impact across Canada's legal spectrum. His presence in the legal community, coupled with his affiliations with prestigious legal associations, underscores his standing as a respected legal practitioner.